Literature DB >> 17511960

Profiling of adipokines secreted from human subcutaneous adipose tissue in response to PPAR agonists.

Eva Klimcakova1, Cedric Moro, Anne Mazzucotelli, Karine Lolmède, Nathalie Viguerie, Jean Galitzky, Vladimir Stich, Dominique Langin.   

Abstract

The role of PPARs in the regulation of human adipose tissue secretome has received little attention despite its potential importance in the therapeutic actions of PPAR agonists. Here, we have investigated the effect of selective PPARgamma, PPARalpha, and PPARbeta/delta agonists on the production of adipokines by human subcutaneous adipose tissue. Antibody arrays were used to measure secreted factors in media from cultured adipose tissue explants. Sixteen proteins were produced in significant amounts. Activation of PPARs regulated the production of five proteins. Treatments with the three PPAR agonists decreased the secretion of leptin and interleukin-6. PPARalpha and beta/delta agonists markedly enhanced hepatocyte growth factor secretion whereas PPARbeta/delta down-regulated angiogenin and up-regulated TIMP-1 release. Hepatocyte growth factor, interleukin-6, and TIMP-1 are chiefly expressed in cells from the stromal vascular fraction whereas angiogenin is expressed in both adipocytes and cells from the stromal vascular fraction. Our data show that PPAR agonists modulate secretion of bioactive molecules from the different cell types composing human adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511960     DOI: 10.1016/j.bbrc.2007.05.012

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue.

Authors:  R W O'Rourke; M D Metcalf; A E White; A Madala; B R Winters; I I Maizlin; B A Jobe; C T Roberts; M K Slifka; D L Marks
Journal:  Int J Obes (Lond)       Date:  2009-06-30       Impact factor: 5.095

2.  Identification and validation of novel adipokines released from primary human adipocytes.

Authors:  Stefan Lehr; Sonja Hartwig; Daniela Lamers; Susanne Famulla; Stefan Müller; Franz-Georg Hanisch; Claude Cuvelier; Johannes Ruige; Kristin Eckardt; D Margriet Ouwens; Henrike Sell; Juergen Eckel
Journal:  Mol Cell Proteomics       Date:  2011-09-26       Impact factor: 5.911

3.  Comparative Secretome Analyses of Primary Murine White and Brown Adipocytes Reveal Novel Adipokines.

Authors:  Asrar Ali Khan; Jenny Hansson; Peter Weber; Sophia Foehr; Jeroen Krijgsveld; Stephan Herzig; Marcel Scheideler
Journal:  Mol Cell Proteomics       Date:  2018-08-22       Impact factor: 5.911

4.  Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans.

Authors:  B Meissburger; L Stachorski; E Röder; G Rudofsky; C Wolfrum
Journal:  Diabetologia       Date:  2011-03-25       Impact factor: 10.122

Review 5.  Inflammatory Mechanisms of Diabetes and Its Vascular Complications.

Authors:  Lyudmila V Nedosugova; Yuliya V Markina; Leyla A Bochkareva; Irina A Kuzina; Nina A Petunina; Irina Y Yudina; Tatiana V Kirichenko
Journal:  Biomedicines       Date:  2022-05-18

Review 6.  Potential applications of global protein expression analysis (proteomics) in morbid obesity and bariatric surgery.

Authors:  Gerald Brandacher; Georg Golderer; Katrin Kienzl; Ernst R Werner; Raimund Margreiter; Helmut G Weiss
Journal:  Obes Surg       Date:  2008-03-11       Impact factor: 4.129

7.  Wdnm1-like, a new adipokine with a role in MMP-2 activation.

Authors:  Yu Wu; Cynthia M Smas
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

Review 8.  The adipocyte as an endocrine cell.

Authors:  Nils Halberg; Ingrid Wernstedt-Asterholm; Philipp E Scherer
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

9.  Increased secretion and expression of myostatin in skeletal muscle from extremely obese women.

Authors:  Dustin S Hittel; Jason R Berggren; Jane Shearer; Kristen Boyle; Joseph A Houmard
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.